A detailed history of Aspiriant, LLC transactions in Nike, Inc. stock. As of the latest transaction made, Aspiriant, LLC holds 5,071 shares of NKE stock, worth $392,495. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,071
Previous 5,130 1.15%
Holding current value
$392,495
Previous $386,000 16.06%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$71.09 - $89.44 $4,194 - $5,276
-59 Reduced 1.15%
5,071 $448,000
Q2 2024

Jul 15, 2024

SELL
$75.37 - $97.18 $56,226 - $72,496
-746 Reduced 12.7%
5,130 $386,000
Q1 2024

Apr 15, 2024

SELL
$92.58 - $107.18 $97,023 - $112,324
-1,048 Reduced 15.14%
5,876 $552,000
Q4 2023

Jan 26, 2024

BUY
$94.56 - $122.64 $6,335 - $8,216
67 Added 0.98%
6,924 $751,000
Q3 2023

Oct 17, 2023

BUY
$89.42 - $110.48 $15,827 - $19,554
177 Added 2.65%
6,857 $655,000
Q2 2023

Jul 19, 2023

BUY
$103.63 - $127.92 $105,080 - $129,710
1,014 Added 17.9%
6,680 $737,000
Q1 2023

Apr 27, 2023

SELL
$116.86 - $129.5 $19,515 - $21,626
-167 Reduced 2.86%
5,666 $694,000
Q4 2022

Jan 23, 2023

BUY
$85.4 - $117.56 $12,810 - $17,634
150 Added 2.64%
5,833 $0
Q3 2022

Oct 28, 2022

BUY
$83.12 - $118.06 $5,818 - $8,264
70 Added 1.25%
5,683 $472,000
Q2 2022

Jul 25, 2022

BUY
$102.2 - $137.05 $1,022 - $1,370
10 Added 0.18%
5,613 $573,000
Q1 2022

May 06, 2022

SELL
$117.57 - $166.39 $30,920 - $43,760
-263 Reduced 4.48%
5,603 $755,000
Q4 2021

Feb 14, 2022

BUY
$147.06 - $177.51 $107,059 - $129,227
728 Added 14.17%
5,866 $979,000
Q3 2021

Oct 27, 2021

SELL
$145.23 - $173.85 $53,008 - $63,455
-365 Reduced 6.63%
5,138 $746,000
Q2 2021

Aug 13, 2021

BUY
$127.11 - $155.95 $58,979 - $72,360
464 Added 9.21%
5,503 $853,000
Q1 2021

May 11, 2021

SELL
$128.64 - $147.05 $22,383 - $25,586
-174 Reduced 3.34%
5,039 $674,000
Q4 2020

Feb 01, 2021

BUY
$120.08 - $144.02 $10,687 - $12,817
89 Added 1.74%
5,213 $737,000
Q3 2020

Oct 29, 2020

SELL
$95.65 - $127.11 $191 - $254
-2 Reduced 0.04%
5,124 $646,000
Q2 2020

Aug 06, 2020

SELL
$78.86 - $104.29 $103,464 - $136,828
-1,312 Reduced 20.38%
5,126 $501,000
Q1 2020

May 05, 2020

SELL
$62.8 - $104.58 $48,356 - $80,526
-770 Reduced 10.68%
6,438 $531,000
Q4 2019

Jan 27, 2020

SELL
$89.18 - $101.57 $11,325 - $12,899
-127 Reduced 1.73%
7,208 $735,000
Q3 2019

Nov 04, 2019

SELL
$78.97 - $93.92 $91,368 - $108,665
-1,157 Reduced 13.62%
7,335 $689,000
Q2 2019

Aug 06, 2019

SELL
$77.14 - $89.2 $72,974 - $84,383
-946 Reduced 10.02%
8,492 $716,000
Q1 2019

May 03, 2019

SELL
$72.75 - $88.01 $98,794 - $119,517
-1,358 Reduced 12.58%
9,438 $800,000
Q4 2018

Feb 04, 2019

SELL
$67.53 - $84.46 $19,583 - $24,493
-290 Reduced 2.62%
10,796 $802,000
Q3 2018

Oct 26, 2018

SELL
$75.53 - $85.55 $34,668 - $39,267
-459 Reduced 3.98%
11,086 $947,000
Q2 2018

Aug 07, 2018

SELL
$64.12 - $79.68 $62,709 - $77,927
-978 Reduced 7.81%
11,545 $920,000
Q1 2018

May 04, 2018

BUY
$62.49 - $69.65 $782,562 - $872,226
12,523 New
12,523 $832,000
Q4 2017

Jan 31, 2018

SELL
$50.83 - $64.81 $851,504 - $1.09 Million
-16,752 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$51.85 - $60.14 $868,591 - $1.01 Million
16,752
16,752 $869,000

Others Institutions Holding NKE

About NIKE, Inc.


  • Ticker NKE
  • Exchange NYSE
  • Sector Consumer Cyclical
  • Industry Footwear & Accessories
  • Shares Outstandng 1,259,689,984
  • Market Cap $97.5B
  • Description
  • NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells men's, women's, and kids athletic footwear, apparel, equipment, and accessories worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chu...
More about NKE
Track This Portfolio

Track Aspiriant, LLC Portfolio

Follow Aspiriant, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.